CVX vs JNJ · P/E 17, rev $118.66B vs P/E 17, rev $49.37B
Chevron Corp (CVX) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
Chevron Corp (CVX) is a oil & gas integrated company listed on US. It is led by Michael K. Wirth.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported CVX revenue for 2026-06-30 was $118.66B. Net income was $14.28B. CVX currently screens at market cap $250.20B and trailing P/E 16.5.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
CVX currently screens at market cap $250.20B and trailing P/E 16.5. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the CVX and JNJ stock pages for the full models.
Not investment advice.